Advertisement

Obesity Surgery

, Volume 19, Issue 1, pp 87–95 | Cite as

The FTO Obesity Gene. Genotyping and Gene Expression Analysis in Morbidly Obese Patients

  • Carina Zabena
  • José L. González-Sánchez
  • María T. Martínez-Larrad
  • Antonio Torres-García
  • Jesús Alvarez-Fernández-Represa
  • Arturo Corbatón-Anchuelo
  • Milagros Pérez-Barba
  • Manuel Serrano-RíosEmail author
Research Article

Abstract

Background

Obesity has emerged as one of the most serious public health concerns in the twenty-first century. the fat mass and obesity associated gene (FTO) has been found to contribute to the risk of obesity in humans. Our aims in this study were to investigate the association of rs9939609 single nucleotide polymorphism (SNP) of the FTO gene with different obesity-related parameters, to assess the FTO gene expression in subcutaneous and visceral adipose tissues from morbidly obese and its correlations with other adipocytokine gene expressions.

Methods

The association between the rs9939609 FTO gene variant and obesity related parameters in 75 obese/morbidly obese adult patients and 180 subjects with body mass index (BMI) < 30 kg/m2 (control group) was examined. Gene expression analyses: subcutaneous adipose tissue samples were obtained from 52 morbidly obese and five subjects with BMI < 30 kg/m2. Visceral adipose tissue was also obtained from 35 morbidly obese patients. Weight, height, BMI, SBP, DBP, fasting glucose, lipid profile, proinsulin, insulin, leptin, and adiponectin (RIA) of patients were also obtained. Insulin resistance by HOMAIR. rs9939609 of FTO genotyping using allele discrimination in real-time PCR. Genomic study of RNA extraction of adipose tissue and real-time PCR (RT-PCR) of adipocytokines and a housekeeping gene were quantified using TaqMan probes. Relative quantification was calculated using the ΔΔ Ct formula.

Results

The minor-(A) allele frequency of rs9939609 FTO gene in the whole population was 0.39. A strong association between this A allele and obesity was found, even after age–sex adjustment (p = 0.013). We found higher levels of FTO mRNA in subcutaneous adipose tissue from morbidly obese than in the control group (p = 0.021). FTO gene expression was lower in visceral than in subcutaneous adipose depot. However, this finding did not reach the level of statistical significance. A negative correlation between subcutaneous FTO gene expression and serum triglyceride levels and a positive correlation with leptin, perilipin, and visfatin gene expressions was found. In the visceral adipose tissue, these positive correlations were statistically significant only for perilipin.

Conclusions

Our results show: (1) A strong association between rs9939609 SNP of the FTO gene variant and obesity in Spanish morbidly obese adult patients; (2) positive correlations between FTO mRNA and leptin, perilipin, and visfatin gene expressions in subcutaneous adipose tissue; (3) FTO and perilipin gene expressions were positively correlated in visceral fat depot. Overall these results may suggest a role of FTO in the regulation of lipolysis as well as in total body fat rather in fat distribution patterns.

Keywords

Obesity FTO Adipocytokines Gene expression Adipose tissue 

Notes

Acknowledgements

We would like to acknowledge hereby the skillful technical assistance of Angeles Asensio-Prianes, Dr. Beatriz Pérez-Villamil for her helpful advice in gene expression methodology, and Dr. Cristina Fernández-Pérez for her helpful support in statistical analysis.

This work is supported with grants from Fundación Mutua Madrileña (FMMA06), FEDER 2FD1997-2309 from Fondo Europeo de Desarrollo Regional; FISS 03/1618 from Fondo de Investigaciones Sanitarias, from Red de Centros RCMN (C03/08), a grant from Instituto de Salud Carlos III—RETIC RD06 (RD06/0015/0012), and CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM). CIBER is an initiative of Instituto de Salud Carlos III.

References

  1. 1.
    Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–102.CrossRefGoogle Scholar
  2. 2.
    Oguma Y, Sesso H, Paffenbarger R, et al. Weight change and risk of developing type 2 diabetes. Obes Res 2005;13:945–51.CrossRefGoogle Scholar
  3. 3.
    Steffes MW, Gross MD, Lee DH, et al. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring). 2006;14:319–26.CrossRefGoogle Scholar
  4. 4.
    Irigaray P, Newby JA, Lacomme S, et al. Overweight/obesity and cancer genesis: more than a biological link. Biomed Pharmacother. 2007;6:665–78.CrossRefGoogle Scholar
  5. 5.
    Barness LA, Opitz JM, Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A. 2007;143:3016–34.CrossRefGoogle Scholar
  6. 6.
    Frühbeck G. The Sir David Cuthbertson Medal Lecture. Hunting for new pieces to the complex puzzle of obesity. Proc Nutr Soc. 2006;65:329–47.PubMedGoogle Scholar
  7. 7.
    Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predispones to childhood and adult obesity. Science 2007;316:889–94.CrossRefGoogle Scholar
  8. 8.
    van der Hoeven F, Schimmang T, Volkmann A, et al. Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). Development. 1994;120:2601–7.PubMedGoogle Scholar
  9. 9.
    Peters T, Ausmeier K, Dildrop R, et al. The mouse Fused toes (Ft) mutation is the result of a 1.6-Mb deletion including the entire Iroquois B gene cluster. Mamm Genome. 2002;13:186–8.CrossRefGoogle Scholar
  10. 10.
    Gerken T, Girard CA, Tung YC, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007;318:1469–72.CrossRefGoogle Scholar
  11. 11.
    Wåhlén K, Sjölin E, Hoffstedt J. The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res. 2008;49:607–11.CrossRefGoogle Scholar
  12. 12.
    Klöting N, Schleinitz D, Ruschke K, et al. Inverse relationship between obesity and FTO gene expression in visceral adipose tissue in humans. Diabetologia. 2008;51:641–7.CrossRefGoogle Scholar
  13. 13.
    Stratigopoulos G, Padilla S, Leduc CA, et al. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1185–96.CrossRefGoogle Scholar
  14. 14.
    Stratakis CA, Lafferty A, Taymans SE, et al. Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13 (D16S419-D16S503). J Clin Endocrinol Metab. 2000;85:3396–401.PubMedGoogle Scholar
  15. 15.
    Gonzalez-Sanchez JL, Zabena C, Martinez-Larrad MT et al. Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain. Clin Endocrinol (Oxf). 2008; doi:  10.1111/j.1365–2265.2008.03335.
  16. 16.
    Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39:724–6.CrossRefGoogle Scholar
  17. 17.
    Scuteri A, Sanna S, Chen WM, et al. Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits. PLoS Genet. 2007;3:e115.CrossRefGoogle Scholar
  18. 18.
    Li H, Wu Y, Loos RJ, et al. Variants in the fat mass-and obesity-associated (FTO) gene are not associated with obesity in a Chinese Han population. Diabetes 2008;57:264–8.CrossRefGoogle Scholar
  19. 19.
    Ohashi J, Naka I, Kimura R, et al. FTO polymorphisms in oceanic populations. J Hum Genet. 2007;52:1031–5.CrossRefGoogle Scholar
  20. 20.
    Martinez-Larrad MT, Fernandez-Perez C, Gonzalez-Sanchez JL, et al. Population-based study of rural and urban areas in the Spanish province of Segovia. Med Clin (Barc). 2005;125:481–6.CrossRefGoogle Scholar
  21. 21.
    Sanchez-Pernaute A, Rubio Herrera MA, Perez-Aguirre E, et al. Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17:1614–8.CrossRefGoogle Scholar
  22. 22.
    Mason EE. Morbid obesity: use of vertical banded gastroplasty. Surg Clin North Am. 1987;67:521–37.CrossRefGoogle Scholar
  23. 23.
    Larrad-Jimenez A, Díaz-Guerra CS, de Cuadros Borrajo P, et al. Short-, mid- and long-term results of Larrad biliopancreatic diversion. Obes Surg 2007;17:202–10.CrossRefGoogle Scholar
  24. 24.
    Diagnosis and Classification of Diabetes Mellitus. ADA. Diabetes Care 2008;31:S55-S60.CrossRefGoogle Scholar
  25. 25.
    Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefGoogle Scholar
  26. 26.
    Ascaso JF, Romero P, Real JT, et al. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a nondiabetic population. Med Clin (Barc). 2001;117:530–3.CrossRefGoogle Scholar
  27. 27.
    Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543–6.CrossRefGoogle Scholar
  28. 28.
    Greenberg AS, Egan JJ, Wek SA, et al. Perilipin, a major hormonally regulated adipocyte specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 1991;266:11341–6.PubMedGoogle Scholar
  29. 29.
    Fasshauer M, Klein J, Neumann S, et al. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002;290:1084–9.CrossRefGoogle Scholar
  30. 30.
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.CrossRefGoogle Scholar
  31. 31.
    Andreasen CH, Stender-Petersen KL, et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes. 2008;57:95–101.CrossRefGoogle Scholar
  32. 32.
    Freathy RM, Timpson NJ, Lawlor DA, et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 2008;57:1419–26.CrossRefGoogle Scholar
  33. 33.
    Perry JR, Frayling TM. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 2008;11:371–7.CrossRefGoogle Scholar
  34. 34.
    Hotta K, Nakata Y, Matsuo T, et al. Variations in the FTO gene are associated with severe obesity in the Japanese. J Hum Genet 2008;53:546–53.CrossRefGoogle Scholar
  35. 35.
    Grant SF, Li M, Bradfield JP, et al. Association analysis of the FTO gene with obesity in children of Caucasian and African ancestry reveals a common tagging SNP. PLoS ONE. 2008;3r:e1746.CrossRefGoogle Scholar
  36. 36.
    Loos RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev 2008;9:246–50.CrossRefGoogle Scholar
  37. 37.
    Ng MC, Park KS, Oh B, et al. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2 and FTO in type 2 diabetes and obesity in 6719 Asians. Diabetes 2008;57:2226–33.CrossRefGoogle Scholar
  38. 38.
    Cha SW, Choi SM, Kim KS et al. Replication of genetic effects of FTO polymorphisms on BMI in a Korean population. Obesity 2008. doi: 10.1038/oby.2008.314 CrossRefGoogle Scholar
  39. 39.
    Chang YC, Liu PH, Lee WJ, et al. Common variation in the FTO gene confers risk of obesity and modulates body mass index in the Chinese population. Diabetes 2008;57:2245–52.CrossRefGoogle Scholar
  40. 40.
    Chu X, Erdman R, Susek M, et al. Association of morbid obesity with FTO and INSIG2 allelic variants. Arch Surg 2008;143:235–40.CrossRefGoogle Scholar
  41. 41.
    Wardle J, Carnell S, Haworth CM et al. Obesity-associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab 2008;93:3640–3.CrossRefGoogle Scholar
  42. 42.
    Speakman JR, Rance KA, Johnstone AM. Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity 2008;16:1961–5.CrossRefGoogle Scholar
  43. 43.
    Haupt A, Thamer C, Machann J, et al. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity 2008;16:1969–72.CrossRefGoogle Scholar
  44. 44.
    Vidal H, Auboeuf D, De Vos P, et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest. 1996;98:251–5.CrossRefGoogle Scholar
  45. 45.
    Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47:913–7.CrossRefGoogle Scholar
  46. 46.
    Bulló M, García-Lorda P, Peinado-Onsurbe J, et al. TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obes Relat Metab Disord. 2002;26:652–8.CrossRefGoogle Scholar
  47. 47.
    Williams LB, Fawcett RL, Waechter AS, et al. Leptin production in adipocytes from morbidly obese subjects: stimulation by dexamethasone, inhibition with troglitazone, and influence of gender. J Clin Endocrinol Metab. 2000;85:2678–84.PubMedGoogle Scholar
  48. 48.
    Fredriksson R, Hägglund M, Olszewski PK, et al. The Obesity Gene, FTO, Is of Ancient Origin, Up-Regulated during Food Deprivation and Expressed in Neurons of Feeding-Related Nuclei of the Brain. Endocrinology. 2008;149:2062–71.CrossRefGoogle Scholar
  49. 49.
    Kern PA, Di Gregorio G, Lu T, et al. Perilipin expression in human adipose tissue is elevated with obesity. J Clin Endocrinol Metab. 2004;89:1352–8.CrossRefGoogle Scholar
  50. 50.
    Lopez-Bermejo A, Petry CJ, Diaz M, et al. The association between the FTO gene and fat mass in humans develops by the postnatal age of two weeks. J Clin Endocrinol Metab. 2008;93:1501–5.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • Carina Zabena
    • 1
  • José L. González-Sánchez
    • 1
  • María T. Martínez-Larrad
    • 1
  • Antonio Torres-García
    • 2
  • Jesús Alvarez-Fernández-Represa
    • 3
  • Arturo Corbatón-Anchuelo
    • 1
  • Milagros Pérez-Barba
    • 1
  • Manuel Serrano-Ríos
    • 1
    Email author
  1. 1.Department of Internal Medicine IIHospital Clínico San Carlos, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)MadridSpain
  2. 2.Department of Surgery IIHospital Clínico San Carlos, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)MadridSpain
  3. 3.Department of Surgery IHospital Clínico San Carlos, CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)MadridSpain

Personalised recommendations